Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems Ortúzar, Maite González López, Jesús Juan Aranda Ballesteros, Elisabet Pharmaceutical active compounds Bioremediation Wastewater Mycoremediation Emerging contaminants Pharmaceutical pollution MO received a Ph.D. grant from the Junta de Castilla y Leon (Spain). Open Access Funding was provided by the University of Helsinki. The presence of emerging contaminants in the environment, such as pharmaceuticals, is a growing global concern. The excessive use of medication globally, together with the recalcitrance of pharmaceuticals in traditional wastewater treatment systems, has caused these compounds to present a severe environmental problem. In recent years, the increase in their availability, access and use of drugs has caused concentrations in water bodies to rise substantially. Considered as emerging contaminants, pharmaceuticals represent a challenge in the field of environmental remediation; therefore, alternative add-on systems for traditional wastewater treatment plants are continuously being developed to mitigate their impact and reduce their effects on the environment and human health. In this review, we describe the current status and impact of pharmaceutical compounds as emerging contaminants, focusing on their presence in water bodies, and analyzing the development of bioremediation systems, especially mycoremediation, for the removal of these pharmaceutical compounds with a special focus on fungal technologies. 2022-05-31T10:44:57Z 2022-05-31T10:44:57Z 2022-04-26 journal article Ortúzar M... [et al.] (2022) Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems. Front. Microbiol. 13:869332. doi: [10.3389/fmicb.2022.869332] http://hdl.handle.net/10481/75138 10.3389/fmicb.2022.869332 eng http://creativecommons.org/licenses/by/3.0/es/ open access Atribución 3.0 España Frontiers